ABIGAIL MCCARTHY: Open Payments
NPI 1376158063 · CAMILLUS, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$569 in 25 payments from 17 companies in 2025. Trend: 2023 $230 · 2024 $535 · 2025 $569
Food & beverage: $569
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 5 | $96 |
| Stryker Corporation | 1 | $60 |
| Corcept Therapeutics | 2 | $56 |
| Merck Sharp & Dohme LLC | 2 | $49 |
| Lundbeck LLC | 2 | $35 |
| ABBVIE INC. | 2 | $34 |
| Indivior Inc. | 1 | $30 |
| Neurocrine BioSciences, Inc. | 1 | $28 |
| Almatica Pharma LLC | 1 | $27 |
| GlaxoSmithKline, LLC. | 1 | $26 |
Products named: FLOWTRIEVER CATHETER, S, Korlym, KISUNLA, MOUNJARO, VYEPTI, QULIPTA, SUBLOCADE, INGREZZA.
Industry payments across NY — which companies pay providers there.
